Feed / FDMT

4D Molecular Therapeutics, Inc.

FDMT

Healthcare · 11.69 +3.5% today

Jodie read · what matters now

4D Molecular Therapeutics, Inc. is being tracked across filings, market groups, and disclosed business relationships.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to FDMT, and whether its market group begins moving.

Latest storyNo Struct brief yetJodie is monitoring new filings.
Disclosed connections21 verified links18 additional receipts in Pro
Organic co-movement groupOncology and Gastrointestinal Biotech · LeaderDiscovered from trading behaviour, not sector labels · Open group →

Who this business touches

The relationships behind FDMT

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

REGNRegeneron Pharmaceuticals, Inc.competitorFull receipt with Pro →

Depended on by

CRSPCRISPR Therapeutics AGcompetitorFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 18 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

FDMT is currently a Leader in the organic co-movement group Oncology and Gastrointestinal Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Theme membership history

No durable theme membership has been observed for this name yet.